Abstract
Biological aging of human organ systems reflects the interplay of age, chronic disease, lifestyle and genetic risk. Using longitudinal organ imaging and physiological phenotypes from the UK Biobank, we establish normative models of biological age for 7 body (cardiovascular, pulmonary, musculoskeletal, immune, renal, hepatic and metabolic) and 3 brain (gray matter, white matter and brain connectivity) systems. We find that an organ’s biological age selectively influences the aging of other organ systems, revealing a multiorgan aging network. Brain age is most strongly influenced by the biological age of the cardiovascular, pulmonary and metabolic systems, whereas the musculoskeletal system is an in-degree hub of the aging network. We report organ age profiles for 16 chronic diseases, where advanced biological aging extends from the organ of primary disease to multiple systems. Advanced body age associates with several lifestyle and environmental factors, leucocyte telomere lengths and mortality risk, and predicts survival time (AUC=0.77) and premature death (AUC=0.86). Our work reveals the multisystem nature of human aging. It may enable early identification of individuals at increased risk of aging-related morbidity and inform new strategies to potentially limit organ-specific biological aging in such individuals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Y.E.T was supported by the Mary Lugton Postdoctoral Fellowship. A.Z. was supported by the National Health and Medical Research Council (NHMRC) grant (APP1142801 and APP118153). V.C. was supported by the NHMRC grant (APP1177370). M.B. was supported by the NHMRC grant (IG2008612, APP1095227 and APP1092623).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC) to obtain and disseminate data and samples from the participants (http://www.ukbiobank.ac.uk/ethics/). Written informed consent was obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Researchers can register to access all data used in this study via the UK Biobank Access Management System (https://bbams.ndph.ox.ac.uk/ams/).
